Example: Heart Attack

Search clinical trials for: HIV Fusion Inhibitors

Total 192 results

NCT04672083

Enrolling by invitation

A Clinical Study of the HIV Drug CPT31 in Healthy Volunteers

Conditions: HIV Infections
NCT02569502

Completed

A Study of Enfuvirtide (Fuzeon) in Patients With Advanced Human Immunodeficiency Virus-1 (HIV-1) Infection

Conditions: HIV Infections
NCT00013884

Completed

HIV Maintenance Therapy With T-20 During HAART Interruption

Conditions: HIV Infection
NCT00120367

Completed

Early Intensification of Antiretroviral Therapy Including Enfuvirtide in HIV-1-Related Progressive Multifocal Leucoencephalopathy (ANRS125)

Conditions: Leukoencephalopathy, Progressive Multifocal; HIV Infections
NCT00082498

Completed

Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients

Conditions: HIV Infections
NCT00089466

Completed

Safety and Activity of the Oral HIV Entry Inhibitor AMD11070 in HIV Infected Patients

Conditions: HIV Infections
NCT00050856

Completed

Fuzeon (Enfuvirtide) Early Access Program for Patients With HIV-1 Infection

Conditions: HIV Infections
NCT02582983

Completed

A Study of Enfuvirtide (Fuzeon) in Participants With Advanced Human Immunodeficiency Virus (HIV) Infection

Conditions: HIV Infections
NCT00001118

Completed

Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children

Conditions: HIV Infections
NCT00021554

Completed

T-20 in HIV Patients With Prior Drug Treatment and/or Resistance to Each of the Three Classes of Anti-HIV Drugs

Conditions: HIV Infections
NCT00008528

Completed

T-20 With Anti-HIV Combination Therapy for Patients With Prior Anti-HIV Drug Treatment and/or Drug Resistance to Each of the Three Classes of Approved Anti-HIV Drugs

Conditions: HIV Infections
NCT02733419

Completed

Efficacy, and Safety Study of Optimized Background Antiretroviral Regimen (OB) in Combination With Enfuvirtide in the Treatment-Experienced Participants With Human Immunodeficiency Virus-1 (HIV-1) Infection

Conditions: HIV Infections
NCT00461266

Withdrawn

ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.

Conditions: HIV Infections
NCT00216359

Unknown status

Cohort Study for Patients Using Fuzeon (Enfuvirtide)

Conditions: HIV Infections; Antiretroviral Treatment
NCT00487188

Completed

A Study to Evaluate the Safety and Efficacy of Adding Enfuvirtide to Oral Highly Active Antiretroviral Therapy (HAART) in Human Immunodeficiency Virus (HIV) Patients With Prior Treatment Experience

Conditions: HIV Infections
NCT00488059

Terminated

A Study of Fuzeon (Enfuvirtide) With an Integrase Inhibitor Plus Optimized Background in Treatment-Experienced HIV-1 Infected Patients

Conditions: HIV Infections
NCT02302547

Completed

Trial to Evaluate the Interest of a Reductive Anti Retroviral Strategy Using Dual Therapy Inspite of Triple Therapy

Conditions: HIV
NCT00925756

Completed

CCR5 Inhibitor Treatment Intensification on CD4+ T-cell Recovery

Conditions: HIV Infections
NCT00326963

Completed

BLQ Study: A Study of a Protease Inhibitor With Fuzeon (Enfuvirtide) in Treatment-Experienced Patients With HIV-1.

Conditions: HIV Infections
NCT01866267

Completed

Switching Undetectables to Selzentry

Conditions: Human Immunodeficiency Virus; AIDS
NCT02741323

Recruiting

Impact of CCR5 Blockade in HIV+ Kidney Transplant Recipients

Conditions: HIV Infections; Kidney Diseases
NCT00735072

Completed

Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure

Conditions: HIV Infection
NCT02486510

Terminated

Effect of Cytoreductive Chemotherapy and a CCR5 Coreceptor Antagonist on HIV-1 Eradication

Conditions: HIV-1 Infection
NCT01049204

Terminated

Impact of Maraviroc on the Immune Function in HIV-1 Infected Subjects Receiving Immunisation With Novel Antigens

Conditions: HIV Infections
NCT01896921

Completed

Switch to Maraviroc + Integrase Inhibitor

Conditions: HIV